Industry News

News from pharmaceutical companies and other related healthcare organizations

News on Signifor, Signifor LAR, and newly approved Cushing’s drug ISTURISA

Recordati Rare Diseases, Inc., based in Lebanon, NJ, has recently acquired the rights to SIGNIFOR® LAR and the FDA approval for ISTURISA®(osilodrostat). Both products...

Questions about access to therapies, financial assistance?

If you are currently taking, or are about to start taking Lanreotide (Somatuline Depot) injections, this website from Ipsen offers a wealth of information...


Articles you may like